Wave Life Sciences (WVE) Non-cash Items (2015 - 2016)
Wave Life Sciences posted quarterly Non-cash Items of $997146.0 for Q2 2016, up 17.56% on a QoQ basis from $848223.0 in Q1 2016.
Wave Life Sciences (WVE) has 2 years of Non-cash Items data on file, last reported at $997146.0 in Q2 2016.
- For the quarter ending Q2 2016, Non-cash Items changed N/A year-over-year to $997146.0; the trailing twelve-month figure through Jun 2016 stood at $997146.0 (changed N/A YoY), and the FY2015 full-year result was $700779.0, changed N/A from the prior year.
- Non-cash Items for Q2 2016 stood at $997146.0, up from $848223.0 in the prior quarter.
- Across five years, Non-cash Items topped out at $997146.0 in Q2 2016 and bottomed at $587170.0 in Q3 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 997,146.00 |
| Jun 30, 2016 | 997,146.00 |
| Mar 31, 2016 | 848,223.00 |
| Mar 31, 2016 | 848,223.00 |
| Dec 31, 2015 | 700,779.00 |
| Dec 31, 2015 | 700,779.00 |
| Sep 30, 2015 | 587,170.00 |
| Sep 30, 2015 | 587,170.00 |